Checkpoint Therapeutics (CKPT) Stock Chart & Stock Price History → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free CKPT Stock Alerts $1.90 +0.01 (+0.53%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Checkpoint Therapeutics Stock Price Performance5 Day Performance+3.26%1 Month Performance+35.71%3 Month Performance-14.80%6 Month Performance-30.66%Year-To-Date Performance-17.03%1 Year Performance-28.57% Receive CKPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. CKPT Stock Chart for Saturday, June, 1, 2024 CKPT Chart by TradingView Checkpoint Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.89$1.90+0.53%$1.93$1.84155,696 shs$67.81 million05/30/2024$1.83$1.89+3.28%$1.92$1.81139,409 shs$67.45 million05/29/2024$1.79$1.83+2.23%$1.85$1.75161,248 shs$65.31 million05/28/2024$1.84$1.79-2.72%$1.90$1.75290,643 shs$63.89 million05/27/2024$1.84$1.84$1.90$1.81219,100 shs$65.67 million05/24/2024$1.84$1.84$1.90$1.81219,043 shs$65.67 million Get the Latest News and Ratings for CKPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.85$1.84-0.54%$1.91$1.80274,331 shs$65.67 million05/22/2024$1.99$1.85-7.04%$2.00$1.85406,613 shs$66.03 million05/21/2024$2.03$1.99-1.97%$2.11$1.901.14 million shs$71.02 million05/20/2024$1.88$2.03+7.98%$2.12$1.89809,834 shs$72.45 million05/17/2024$1.78$1.88+5.62%$1.93$1.74493,551 shs$67.10 million05/16/2024$1.63$1.78+9.20%$1.82$1.60983,064 shs$63.53 million05/15/2024$1.56$1.63+4.49%$1.64$1.55260,859 shs$58.18 million05/14/2024$1.54$1.56+1.30%$1.60$1.54311,797 shs$55.67 million05/13/2024$1.50$1.54+2.67%$1.57$1.51297,288 shs$54.96 million05/10/2024$1.56$1.50-3.85%$1.61$1.47943,224 shs$53.53 million05/09/2024$1.62$1.56-3.70%$1.65$1.56337,997 shs$55.67 million05/08/2024$1.69$1.62-4.14%$1.70$1.62242,179 shs$57.82 million05/07/2024$1.63$1.69+3.68%$1.75$1.63262,450 shs$60.32 million05/06/2024$1.58$1.63+3.16%$1.68$1.58277,616 shs$58.18 million05/03/2024$1.48$1.58+6.76%$1.70$1.47614,307 shs$56.39 million05/02/2024$1.40$1.48+5.71%$1.51$1.39324,599 shs$52.82 million05/01/2024$1.39$1.40+0.72%$1.44$1.38174,166 shs$49.97 million04/30/2024$1.44$1.39-3.14%$1.47$1.39177,198 shs$49.61 million04/29/2024$1.43$1.44+0.35%$1.53$1.42341,006 shs$51.21 million04/26/2024$1.42$1.43+0.70%$1.46$1.39541,824 shs$51.04 million04/25/2024$1.44$1.42-1.39%$1.50$1.41166,048 shs$50.68 million04/24/2024$1.44$1.44+0.35%$1.48$1.42183,824 shs$51.39 million04/23/2024$1.45$1.44-1.03%$1.52$1.42352,028 shs$51.22 million04/22/2024$1.46$1.45-0.68%$1.54$1.41458,413 shs$51.75 million04/19/2024$1.60$1.46-8.75%$1.68$1.45755,018 shs$52.11 million04/18/2024$1.67$1.60-4.19%$1.72$1.59469,359 shs$57.10 million04/17/2024$1.69$1.67-1.18%$1.72$1.66267,826 shs$59.60 million04/16/2024$1.72$1.69-1.74%$1.77$1.66506,930 shs$60.32 million04/15/2024$1.78$1.72-3.37%$1.76$1.68469,215 shs$61.38 million04/12/2024$1.83$1.78-2.73%$1.86$1.75271,968 shs$63.53 million04/11/2024$1.78$1.83+2.81%$1.86$1.76300,312 shs$65.31 million04/10/2024$1.83$1.78-2.73%$1.83$1.76353,710 shs$63.53 million04/09/2024$1.82$1.83+0.55%$1.88$1.78249,995 shs$65.31 million04/08/2024$1.83$1.82-0.55%$1.89$1.77305,688 shs$64.96 million[Urgent!] Generational Wealth Gameplan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide04/05/2024$1.87$1.83-2.14%$1.94$1.82371,395 shs$65.31 million04/04/2024$1.92$1.87-2.60%$1.95$1.85262,256 shs$66.74 million04/03/2024$1.92$1.92$1.96$1.90243,655 shs$68.53 million04/02/2024$2.02$1.92-4.95%$2.01$1.89305,408 shs$68.53 million04/01/2024$2.05$2.02-1.46%$2.08$2.00356,864 shs$47.52 million03/29/2024$2.05$2.05$2.10$2.02345,753 shs$48.24 million03/28/2024$2.04$2.05+0.49%$2.10$2.02345,753 shs$48.24 million03/27/2024$2.07$2.04-1.45%$2.10$2.00251,912 shs$48.00 million03/26/2024$2.00$2.07+3.50%$2.15$2.00471,163 shs$48.71 million03/25/2024$1.94$2.00+3.09%$2.06$1.92450,034 shs$47.06 million03/22/2024$1.90$1.94+2.11%$1.99$1.85493,118 shs$45.65 million03/21/2024$1.88$1.90+1.06%$1.95$1.87410,454 shs$44.70 million03/20/2024$1.85$1.88+1.62%$1.92$1.80377,861 shs$44.24 million03/19/2024$1.89$1.85-2.12%$1.94$1.85341,091 shs$43.53 million03/18/2024$1.92$1.89-1.56%$2.01$1.87392,309 shs$44.47 million03/15/2024$1.85$1.92+3.78%$1.94$1.88378,608 shs$45.18 million03/14/2024$1.95$1.85-5.13%$2.01$1.85401,662 shs$43.53 million03/13/2024$2.00$1.95-2.50%$2.09$1.95316,347 shs$45.88 million03/12/2024$2.15$2.00-6.98%$2.15$2.00272,879 shs$47.06 million03/11/2024$2.14$2.15+0.70%$2.23$2.11343,147 shs$50.59 million03/08/2024$2.17$2.14-1.61%$2.24$2.12272,592 shs$50.24 million03/07/2024$2.21$2.17-1.81%$2.21$2.11251,776 shs$51.05 million03/06/2024$2.23$2.21-0.90%$2.35$2.18362,457 shs$52.00 million03/05/2024$2.32$2.23-3.88%$2.34$2.20385,258 shs$52.47 million03/04/2024$2.23$2.32+4.04%$2.33$2.20569,292 shs$54.59 million03/01/2024$2.09$2.23+6.70%$2.33$2.10613,490 shs$52.47 million02/29/2024$2.05$2.09+1.95%$2.15$2.07243,451 shs$49.18 million Related Companies: Leap Therapeutics Stock Chart Enanta Pharmaceuticals Stock Chart XBiotech Stock Chart Immutep Stock Chart Emergent BioSolutions Stock Chart 23andMe Stock Chart Design Therapeutics Stock Chart Acrivon Therapeutics Stock Chart Foghorn Therapeutics Stock Chart Aldeyra Therapeutics Stock Chart Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CKPT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.